Megakaryocyte colony‐stimulating factor (Meg‐CSF) is a unique cytokine specific for the megakaryocyte lineage

Publisher Website
Google Scholar
Abstract
Summary. The regulation of megakaryocytopoiesis and platelet production has not yet been clearly elucidated. Several cytokines have been shown to be capable of producing megakaryocyte colonies from bone marrow [i.e. Inter‐leukin (IL)‐3, granulocyte‐macrophage (GM)‐ colony‐stimulating factor (CSF), erythropoietin (Epo)]. In addition, other activities have been reported to stimulate megakaryocyte precursors, yet a megakaryocyte‐CSF (Meg‐CSF) has not been purified to homogeneity and IL‐3, GM‐CSF and/or Epo often contaminate purification attempts which could account for the activities. A Meg‐CSF has been isolated from the urine of patients with aplastic anaemia and purified by sequential ultrafiltration, cation exchange, G‐50 chromotography, pre‐parative PAGE, chromatofocusing and cation exchange HPLC. The activity of this material is 2−4 × 104 CFU‐Meg/mg as measured in a murine marrow, serum‐containing assay. This activity also stimulates CFU‐Meg in the absence of adherent accessory cells and in serum‐free cultures, indicative of the direct stimulation on CFU‐Meg. Immunoassays, colony forming assays, and proliferation assays demonstrate that purified Meg‐CSF has no GM‐CSF, IL‐3, M‐CSF, G‐CSF or IL‐1a, −3, −6, −9 and −11. In confirmation of these results, neutralizing antibody to IL‐6 also did not abrogate Meg‐CSF activity. Therefore the previously‐reported megakaryocyte colony‐stimulating activity in purified aplastic anaemia patient urine is due to a unique cytokine: Meg‐CSF.